William Hardy
Internal Medicine · Los Angeles, CANPI 1760410518
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Viiv Healthcare Company accounts for 80.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $166,985 and has fallen 59.1% since, to $68,284 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $1453.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$563K
- Janssen Products, LP$45K
- Merck$31K
- GSK$19K
- Gilead$18K
- EMD Serono, Inc.$17K
- plus $11K from 7 others
Across 3 payments — averaging $35,458 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$89K
- Gilead$17K
What the payments were for
- Consulting fees$320,24646%
- Speaking & faculty fees$271,00039%
- Grants$2510%
- Travel & lodging$101,35914%
- Food & beverage$10,8102%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 352 | $562,593 |
| Janssen Products, LP | 36 | $45,168 |
| Merck | 34 | $30,901 |
| GSK | 13 | $18,740 |
| Gilead | 19 | $17,706 |
| EMD Serono, Inc. | 9 | $17,267 |
| CSL Behring | 2 | $5,000 |
| Theratechnologies Inc. | 3 | $2,539 |
| Actelion Pharmaceuticals US, Inc. | 1 | $2,320 |
| Tersera Therapeutics LLC | 1 | $688 |
| Janssen Scientific Affairs, LLC | 3 | $324 |
| Johnson & Johnson | 10 | $307 |
| Cook Medical LLC | 1 | $113 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$703,666 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HorizantGabapentin Enacarbil | 12 | $5,880 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Los Angeles
- Soha DolatabadiLos Angeles$458K
- Matthew HerrmannLos Angeles$384K
- Koppany VisnyeiLos Angeles$287K
- Jaime BetancourtLos Angeles$286K
- William KingLos Angeles$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.